| 105166-3 |
Multisection^WO contrast |
Find |
Head>Brain |
Pt |
Doc |
MR.functional |
|
ACTIVE |
Functional MR Brain WO contrast |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
105166-3 |
|
MR.functional |
|
|
Both |
|
|
|
0 |
fMR Brain WO contr |
|
|
|
N |
|
Brain; c; Cerebral; Cerebrum; Contr; Contra; Contrst; Cranial; Cranium; Document; Finding; Findings; fMR; fMRI; Functional MRI; Head; Imaging; Intracranial; Mitral regurgitation maximum velocity; MRI; MRI.function; Point in time; Radiology; Random; Skull; without contrast |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 105167-1 |
Multisection cine for function^WO contrast |
Find |
Chest>Heart |
Pt |
Doc |
MR |
|
ACTIVE |
MR Heart cine for function WO contrast |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
105167-1 |
|
MR |
|
|
Both |
|
|
|
0 |
MR Hrt Cine for Function WO contr |
|
|
|
N |
|
c; Cardiac; Cinematographic; Contr; Contra; Contrst; Document; FCN; Finding; Findings; Func; Funct; Hrt; Imaging; Mitral regurgitation maximum velocity; MRI; Point in time; Radiology; Random; Thorax; without contrast |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 105168-9 |
Multisection cine for function^WO & W contrast IV |
Find |
Chest>Heart |
Pt |
Doc |
MR |
|
ACTIVE |
MR Heart cine for function WO and W contrast IV |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
105168-9 |
|
MR |
|
|
Both |
|
|
|
0 |
MR Hrt Cine for Function WO+W contr IV |
|
|
|
N |
|
c; Cardiac; Cinematographic; Contr; Contra; Contrst; Document; FCN; Finding; Findings; Func; Funct; Hrt; Imaging; Mitral regurgitation maximum velocity; MRI; Point in time; Radiology; Random; Thorax; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 105169-7 |
Multisection cine for function^W contrast IV |
Find |
Chest>Heart |
Pt |
Doc |
MR |
|
ACTIVE |
MR Heart cine for function W contrast IV |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
105169-7 |
|
MR |
|
|
Both |
|
|
|
0 |
MR Hrt Cine for Function W contr IV |
|
|
|
N |
|
c; Cardiac; Cinematographic; Contr; Contra; Contrst; Document; FCN; Finding; Findings; Func; Funct; Hrt; Imaging; Mitral regurgitation maximum velocity; MRI; Point in time; Radiology; Random; Thorax; W contr IV; WC |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 10517-1 |
Trypsin Ag |
PrThr |
Tiss |
Pt |
Ord |
Immune stain |
|
ACTIVE |
Trypsin Ag [Presence] in Tissue by Immune stain |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH |
|
10517-1 |
|
Immune stain |
|
|
Both |
|
|
|
0 |
Trypsin Ag Tiss Ql ImStn |
|
|
|
|
|
Antigen; Antigens; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Ordinal; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Tissue; Tissue, unspecified; TPS |
2.56 |
1.0i |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 105170-5 |
Multisection^WO contrast IV |
Find |
Chest>Heart |
Pt |
Doc |
MR.angio |
|
ACTIVE |
MRA Heart WO contrast IV |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
105170-5 |
|
MR.angio |
|
|
Both |
|
|
|
0 |
MRA Hrt |
|
|
|
N |
|
Ang; Angio; Angiography; c; Cardiac; Contr; Contra; Contrst; Document; Finding; Findings; Hrt; Imaging; Magnetic Resonance Angiographies; Magnetic resonance imaging; Mitral regurgitation maximum velocity; MR angiography; MRA; MRI; MRI.angio; Point in time; Radiology; Random; Thorax; without contrast |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 105171-3 |
Multisection^W contrast IV |
Find |
Chest>Heart |
Pt |
Doc |
MR.angio |
|
ACTIVE |
MRA Heart W contrast IV |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
105171-3 |
|
MR.angio |
|
|
Both |
|
|
|
0 |
MRA Hrt W contr IV |
|
|
|
N |
|
Ang; Angio; Angiography; c; Cardiac; Contr; Contra; Contrst; Document; Finding; Findings; Hrt; Imaging; Magnetic Resonance Angiographies; Magnetic resonance imaging; Mitral regurgitation maximum velocity; MR angiography; MRA; MRI; MRI.angio; Point in time; Radiology; Random; Thorax; W contr IV; WC |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 105172-1 |
Multisection^WO & W contrast IV |
Find |
Chest>Heart |
Pt |
Doc |
MR.angio |
|
ACTIVE |
MRA Heart WO and W contrast IV |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
105172-1 |
|
MR.angio |
|
|
Both |
|
|
|
0 |
MRA Hrt WO+W contr IV |
|
|
|
N |
|
Ang; Angio; Angiography; c; Cardiac; Contr; Contra; Contrst; Document; Finding; Findings; Hrt; Imaging; Magnetic Resonance Angiographies; Magnetic resonance imaging; Mitral regurgitation maximum velocity; MR angiography; MRA; MRI; MRI.angio; Point in time; Radiology; Random; Thorax; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 105173-9 |
Multisection cine for blood flow velocity mapping^WO contrast IV |
Find |
Chest>Heart |
Pt |
Doc |
MR |
|
ACTIVE |
MR Heart cine for blood flow velocity mapping WO contrast IV |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
105173-9 |
|
MR |
|
|
Both |
|
|
|
0 |
MR Hrt Cine for Flow VM |
|
|
|
N |
|
Bld flow; Bld flow vel; Bld flow.velocity; c; Cardiac; Cine for Flow VM; Cinematographic; Contr; Contra; Contrst; Document; Dynamic; Finding; Findings; Hrt; Imaging; Mitral regurgitation maximum velocity; MRI; Point in time; Radiology; Random; Thorax; Vel; without contrast |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 105174-7 |
Multisection cine for blood flow velocity mapping^WO & W contrast IV |
Find |
Chest>Heart |
Pt |
Doc |
MR |
|
ACTIVE |
MR Heart cine for blood flow velocity mapping WO and W contrast IV |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
105174-7 |
|
MR |
|
|
Both |
|
|
|
0 |
MR Hrt Cine for Flow VM WO+W contr IV |
|
|
|
N |
|
Bld flow; Bld flow vel; Bld flow.velocity; c; Cardiac; Cine for Flow VM; Cinematographic; Contr; Contra; Contrst; Document; Dynamic; Finding; Findings; Hrt; Imaging; Mitral regurgitation maximum velocity; MRI; Point in time; Radiology; Random; Thorax; Vel; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 105175-4 |
Functional assessment standardized items (FASI) - v1.1 |
- |
^Patient |
RptPeriod |
- |
CMS Assessment |
|
ACTIVE |
Functional assessment standardized items (FASI) - v1.1 during assessment period [CMS Assessment] |
|
PANEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.SURVEY.CMS |
|
105175-4 |
|
CMS Assessment |
|
|
Order |
|
|
|
0 |
|
|
|
|
N |
|
Centers for Medicare and Medicaid Assessment; FASI - v1.1; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey |
2.8 |
2.78 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 105176-2 |
Living Arrangements |
- |
^Patient |
RptPeriod |
- |
CMS Assessment |
|
ACTIVE |
|
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.SURVEY.CMS |
|
105176-2 |
|
CMS Assessment |
|
|
Subset |
|
|
|
0 |
|
|
|
|
N |
|
Centers for Medicare and Medicaid Assessment; Housing; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey |
2.8 |
2.8 |
|
Organizer |
|
|
|
|
|
|
|
|
|
0 |
| 105177-0 |
I have indicated all the devices needed |
Find |
^Patient |
RptPeriod |
Ord |
CMS Assessment |
|
ACTIVE |
|
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.CMS |
|
105177-0 |
|
CMS Assessment |
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey |
2.8 |
2.8 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 105178-8 |
Invasive Trophoblast Ag |
PrThr |
Tiss |
Pt |
Ord |
Immune stain |
|
ACTIVE |
Invasive trophoblast Ag [Presence] in Tissue by Immune stain |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
105178-8 |
|
Immune stain |
|
|
Both |
|
|
|
0 |
ITA tiss Ql ImStn |
|
|
|
N |
|
Antigen; Antigens; Chemistry; Hyperglycosylated hCG; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; ITA; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Tissue; Tissue, unspecified |
2.79 |
2.78 |
|
|
|
|
|
|
|
|
|
|
Release 2.79: SYSTEM: correcting to agreed upon representation; |
0 |
| 105179-6 |
Aztreonam+Avibactam |
Susc |
Isolate |
Pt |
OrdQn |
Gradient strip |
|
ACTIVE |
Aztreonam+Avibactam [Susceptibility] by Gradient strip |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
105179-6 |
|
Gradient strip |
|
|
Observation |
|
|
|
0 |
Aztreonam+Avibactam Islt Grad strip |
|
|
|
N |
|
ANTIBIOTIC SUSCEPTIBILITIES; AST; Azactam; Azaj; azthreonam; Epsilometer; Estrip; E-strip; Grad strip; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 10518-9 |
Ulex europaeus I lectin Ag |
PrThr |
Tiss |
Pt |
Ord |
Immune stain |
|
ACTIVE |
Ulex europaeus I lectin Ag [Presence] in Tissue by Immune stain |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH |
|
10518-9 |
|
Immune stain |
|
|
Both |
|
|
|
0 |
UEA1 Ag Tiss Ql ImStn |
|
|
|
|
|
Antigen; Antigens; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Ordinal; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Tissue; Tissue, unspecified; UEA1; UEA-1 |
2.56 |
1.0i |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 10519-7 |
Vimentin Ag |
PrThr |
Tiss |
Pt |
Ord |
Immune stain |
|
ACTIVE |
Vimentin Ag [Presence] in Tissue by Immune stain |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH |
|
10519-7 |
|
Immune stain |
|
|
Both |
|
|
|
0 |
Vimentin Ag Tiss Ql ImStn |
|
|
|
|
|
Antigen; Antigens; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Ordinal; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Tissue; Tissue, unspecified; Tumor marker |
2.73 |
1.0i |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 105193-7 |
Treponema pallidum Ab.IgG Index |
ACnc |
Ser+CSF |
Pt |
Qn |
|
|
ACTIVE |
Treponema pallidum IgG Ab index [Units/volume] in Serum and CSF |
|
ADD |
DefinitionDescription |
|
|
index |
|
|
|
|
|
|
MICRO |
|
105193-7 |
|
|
|
|
Both |
|
|
|
0 |
T pallidum IgG Index Ser+CSF-aCnc |
|
|
|
N |
|
ABS; Aby; AI; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Both serum and cerebrospinal fluid; Cerebral spinal fluid; Cerebrospinal Fl; Immune globulin G; Immunoglobulin G; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SR; Syphilis; T pallidum; T pallidum Ab.IgG Index; Treponemal |
2.78 |
2.78 |
|
|
|
|
|
|
|
{Index_val} |
|
|
|
0 |
| 105194-5 |
Risankizumab Ab panel |
- |
Ser/Plas |
Pt |
- |
|
|
ACTIVE |
Risankizumab Ab panel - Serum or Plasma |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHEM |
|
105194-5 |
|
|
|
|
Order |
|
|
|
0 |
Risankizumab Ab pnl SerPl |
|
|
|
N |
|
Chemistry; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; Risankizumab Ab pnl; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.78 |
2.78 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 105195-2 |
Risankizumab Ab |
MCnc |
Ser/Plas |
Pt |
Qn |
IA |
|
ACTIVE |
Risankizumab Ab [Mass/volume] in Serum or Plasma by Immunoassay |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
CHEM |
|
105195-2 |
|
IA |
|
|
Observation |
|
|
|
0 |
Risankizumab Ab SerPl IA-mCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Chemistry; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Level; Mass concentration; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS |
2.78 |
2.78 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 105196-0 |
Inflammatory Bowel Disease multigene analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Molgen |
|
ACTIVE |
Inflammatory bowel disease multigene analysis in Blood or Tissue Document by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
105196-0 |
|
Molgen |
|
|
Order |
|
|
|
0 |
IBD multi Bld/T Doc |
|
|
|
N |
|
Blood; Dis; Diseases; Document; Dz; Finding; Findings; Gene; Gene panel; IBD; IBD multi; Molecular genetics; Multi-gene study; Multiple-gene panel test; PCR; Point in time; Random; Serology; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 105197-8 |
Hereditary nonpolyposis colorectal cancer multigene analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Molgen |
|
ACTIVE |
Hereditary nonpolyposis colorectal cancer multigene analysis in Blood or Tissue by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
105197-8 |
|
Molgen |
|
|
Order |
|
|
|
0 |
HNPCC multi Bld/T |
|
|
|
N |
|
Blood; Document; Finding; Findings; Gene; Gene panel; HNPCC multi; Lynch syndrome; Molecular genetics; Molecular pathology; MOLPATH; Multi-gene study; Multiple-gene panel test; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 105198-6 |
Marfan and related conditions multigene analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Molgen |
|
ACTIVE |
Marfan and related conditions multigene analysis in Blood or Tissue by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
105198-6 |
|
Molgen |
|
|
Order |
|
|
|
0 |
Marfan & related cond multi anly Bld/T |
|
|
|
N |
|
Blood; Document; Finding; Findings; Gene; Gene panel; Marfan & related cond multi anly; Molecular genetics; Molecular pathology; MOLPATH; Multi-gene study; Multiple-gene panel test; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 105199-4 |
Noonan syndrome and related conditions multigene analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Molgen |
|
ACTIVE |
Noonan syndrome and related conditions multigene analysis in Blood or Tissue by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
105199-4 |
|
Molgen |
|
|
Order |
|
|
|
0 |
Noonan syn & rel cond multi anly Bld/T |
|
|
|
N |
|
Blood; Document; Finding; Findings; Gene; Gene panel; Molecular genetics; Molecular pathology; MOLPATH; Multi-gene study; Multiple-gene panel test; Noonan syn & rel cond multi anly; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 1052-0 |
I (int) subtype |
ACnc |
Ser/Plas^BPU |
Pt |
Ord |
Aggl RBC |
|
DEPRECATED |
Deprecated I (intermediate) subtype [Presence] in Serum or Plasma from Blood product unit |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
1052-0 |
|
Aggl RBC |
|
|
|
|
|
|
0 |
Deprecated I (Int) Subtyp SerPl BPU Ql |
|
|
|
|
|
Agg; Agglut; Agglutination; Arbitrary Concentration; BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Ordinal; Pl; Plasma; Plsm; Point in time; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPl^bpu; SerPlas; Serum; Serum or plasma; SR |
2.4 |
1 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
